Table 1.
Inhibitor | PARP1 |
TNKS1 |
||||||
---|---|---|---|---|---|---|---|---|
kon (M−1 s−1) | koff (s−1) | t1/2 (min) | Kin. KD (nM) | kon (M−1 s−1) | koff (s−1) | t1/2 (min) | Kin. KD (nM) | |
Talazoparib | 1.3 × 105 | 7.3 × 10−5 | 158 | 0.6 ± 0.1 | 1.8 × 105 | 2.6 × 10−3 | 4 | 14 ± 1 |
Olaparib | 1.1 × 105 | 8.8 × 10−5 | 131 | 0.8 ± 0.1 | 1.1 × 105 | 1.7 × 10−1 | 0.1 | 1700 ± 6 |
Veliparib | 7.5 × 105 | 3.6 × 10−3 | 5 | 6.2 ± 3.5 | 3.1 × 103 | 5.4 × 10−2 | 0.2 | 17,500 ± 300 |
Niraparib | 3.4 × 105 | 1.7 × 10−3 | 7 | 5.4 ± 1.4 | 2.5 × 104 | 8.3 × 10−1 | 0.01 | 34,800 ± 540 |
Binding kinetics measured in 25 mM Hepes, 150 mM NaCl, 5% glycerol, 0.5 mM TCEP, 2% DMSO, 0.02% Tween 20, and pH 7.4, at 25 °C.
Each value in the table represents an average of two or more independent measurements.